滚动资讯
FierceBiotechSalspera plans $91M IPO to fund phase 3 studies of salmonella-based cancer therapyAgilent吉姆·克莱默评安捷伦科技：“我认为你不需要它” - 雅虎财经Endpoints NewsRA Capital, Forbion and Canaan appear to back Harbour's CTLA-4 partner SolsticeBioPharma DiveWith $100M, Vima pursues an oral drug for movement disordersIlluminaCapital International Inc. CA Boosts Stake in Illumina - National TodayIlluminaCapital International Inc. CA Boosts Stock Holdings in Illumina, Inc. $ILMN - MarketBeatThermo Fisher蒙特利尔银行持有赛默飞世尔科技公司价值2.4714亿美元股份——MarketBeatThermo FisherThermo Fisher Scientific (TMO) 股价近期疲软后，估值是否合理？ - simplywall.steLifeReplacing the immune system of the brainEndpoints News研究表明长链非编码RNA有望成为新型基因药物类别Cell健康人体内免疫-微生物组协调决定干扰素设定点Cell在计算机上以四维方式赋予基因最小细胞生命

资讯库

最新 最旧
总数 6091
页码 25 / 339
搜索 --

目录

59 全部